Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Introduction

Peripheral arterial disease (PAD) is a marker of significant atherosclerotic cardiovascular disease and is associated with greater healthcare burden and worse prognosis in individuals with chronic inflammatory disease (CID). We aimed to investigate temporal trends and disparities of PAD-related mortality in populations with CID from 1999-2020 across six common CIDs (., chronic viral hepatitis, human immunodeficiency virus, inflammatory bowel disease, psoriasis, rheumatoid arthritis, and systemic lupus erythematosus).

Methods

United States (US) PAD and CID-related mortality and demographic data from 1999-2020 were extracted from the CDC database through the multiple-cause-of-death files. Age-adjusted mortality rates (AAMR) per 1,000,000 and 95% confidence intervals were standardized to the 2000 US population. The mortality trends were analyzed using Joinpoint Regression.

Results

A total of 22,175 PAD-related deaths were recorded in the population with CID between 1999 and 2020. Mortality remained stable during the 22-year period (AAPC -0.04%, 0.95) with a cumulative AAMR of 4.64. Mortality was highest in rural counties (AAMR 5.27), and among non-Hispanic Black populations (AAMR 7.06). Among the CID subtypes, PAD mortality was highest in populations with RA (AAMR 2.48) and lowest in populations with psoriasis (AAMR 0.11).

Conclusion

Our findings highlight the disparities of PAD mortality in patients with CID, with the Black population and rural communities disproportionately affected. Further investigation with individual-level data is warranted to identify the contributing factors for the observed disparities.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X353038241125050631
2024-12-10
2025-08-21

  • From This Site

    /content/journals/ccr/10.2174/011573403X353038241125050631
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SelvinE. ErlingerT.P. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000.Circulation2004110673874310.1161/01.CIR.0000137913.26087.F0 15262830
     [Google Scholar]
  2. IssaR. NazirS. Khan MinhasA.M. Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019.Vasc. Med.202328320521310.1177/1358863X221140151 36597656
     [Google Scholar]
  3. GroenendykJ.W. RiveraA.S. SinhaA. Lloyd-JonesD.M. FeinsteinM.J. Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018.Sci. Rep.20211112398510.1038/s41598‑021‑03407‑4 34907262
     [Google Scholar]
  4. CDC Wonder 2024 Available from: https://wonder.cdc.gov (accessed on 12-11-2024).
  5. AndersonR.N. RosenbergH.M. Age standardization of death rates: implementation of the year 2000 standard.Natl. Vital Stat. Rep.1998473116, 20 9796247
     [Google Scholar]
  6. Joinpoint Trend Analysis Software Available from: https://surveillance.cancer.gov/joinpoint/ (accessed on 12-11-2024).
  7. BenjaminO. GoyalA. LappinS.L. Disease-modifying antirheumatic drugs (DMARD).StatPearls.StatPearls Publishing2024
     [Google Scholar]
  8. NegreiC. BojincaV. BalanescuA. Management of rheumatoid arthritis: Impact and risks of various therapeutic approaches.Exp. Ther. Med.20161141177118310.3892/etm.2016.3045 27073419
     [Google Scholar]
  9. JaniM. BartonA. WarrenR.B. GriffithsC.E.M. ChinoyH. The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.Rheumatology (Oxford)201453221322210.1093/rheumatology/ket260 23946436
     [Google Scholar]
  10. SmolenJ.S. AletahaD. McInnesI.B. Rheumatoid arthritis.Lancet2016388100552023203810.1016/S0140‑6736(16)30173‑8 27156434
     [Google Scholar]
  11. AdamichouC. BertsiasG. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies.Mediterr. J. Rheumatol.201728141210.31138/mjr.28.1.4 32185248
     [Google Scholar]
  12. McMahonM. SetoR. SkaggsB.J. Cardiovascular disease in systemic lupus erythematosus.Rheumatol. Immunol. Res.20212315717210.2478/rir‑2021‑0022 35880242
     [Google Scholar]
  13. MenniniF.S. MarcellusiA. Robbins ScottS. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.Liver Int.202141593494810.1111/liv.14808 33529499
     [Google Scholar]
  14. KhooT. LamD. OlynykJ.K. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease.World J. Gastroenterol.202127294831484510.3748/wjg.v27.i29.4831 34447229
     [Google Scholar]
  15. NegroF. Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases.J. Hepatol.2014611S69S7810.1016/j.jhep.2014.08.003 25443347
     [Google Scholar]
  16. ChangW.H. MuellerS.H. ChungS.C. FosterG.R. LaiA.G. Increased burden of cardiovascular disease in people with liver disease: Unequal geographical variations, risk factors and excess years of life lost.J. Transl. Med.2022201210.1186/s12967‑021‑03210‑9 34980174
     [Google Scholar]
  17. DemsasF. JoinerM.M. TelmaK. FloresA.M. TekluS. RossE.G. Disparities in peripheral artery disease care: A review and call for action.Semin. Vasc. Surg.202235214115410.1053/j.semvascsurg.2022.05.003 35672104
     [Google Scholar]
  18. AllisonM.A. HoE. DenenbergJ.O. Ethnic-specific prevalence of peripheral arterial disease in the United States.Am. J. Prev. Med.200732432833310.1016/j.amepre.2006.12.010 17383564
     [Google Scholar]
  19. TravenS.A. SynovecJ.D. WaltonZ.J. LeddyL.R. SuleimanL.I. GrossC.E. Notable racial and ethnic disparities persist in lower extremity amputations for critical limb ischemia and infection.J. Am. Acad. Orthop. Surg.2020282188589210.5435/JAAOS‑D‑19‑00630 31934928
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X353038241125050631
Loading
Disparities in Peripheral Artery Disease-related Mortality in Chronic Inflammatory Disease in the United States from 1999 to 2020
Curr. Cardiol. Rev. 21, E1573403X353038 (2025); https://doi.org/10.2174/011573403X353038241125050631
/content/journals/ccr/10.2174/011573403X353038241125050631
/content/journals/ccr/10.2174/011573403X353038241125050631
Loading

Data & Media loading...

Supplements

Supplementary material, along with the published article, is available on the publisher's website.

file format download Download

  • Article Type:     Research Article
Keyword(s): atherosclerotic cardiovascular disease; black populations; chronic inflammatory; chronic inflammatory disease; demographic data; Peripheral artery disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test